If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £53.99m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Placing of Shares

26 May 2006 07:01

Hardide PLC26 May 2006 Press Release 26 May 2006 Hardide Plc ("Hardide" or "the Company") Placing of Shares Hardide Plc (AIM:HDD), the provider of unique surface engineering technologyannounces that it has conditionally raised £1.55 million (before expenses) forthe Company via a placing for cash of 12,386,832 Ordinary Shares of 1 pence each("Ordinary Shares") at 12.5 pence per share ("the Placing"). In addition,601,650 Ordinary Shares held by Dr Yuri Zhuk, Technical Director of Hardide, and8,598,350 Ordinary Shares held by Flintstone Management Services Limited ("FMS"), a subsidiary of Proventec PLC, have also been placed at the placingprice with institutional and other investors. The net receivable proceeds of the Placing will be used to fund the Company'scontinuing expansion. Mr David Chestnutt, non-executive Chairman of Hardide, is also a director ofFMS. FMS has undertaken not to dispose of any further Ordinary Shares withoutthe permission of the Company's broker, Daniel Stewart & Co plc, before 30November 2006. Application has been made for the admission of the 12,386,832 Ordinary Sharessubject to the Placing to be admitted to trading on AIM ("Admission"). It isexpected that Admission will take place on 1 June 2006. At Admission, theCompany will have 146,742,236 Ordinary Shares in issue. Jim Murray-Smith, Chief Executive of the Company, has subscribed for 200,000Ordinary Shares in the Placing. Following Admission, Mr Murray-Smith will havean interest in 428,000 Ordinary Shares, representing 0.27% of the issued sharecapital. Following Admission, Dr Zhuk will have a residual interest in 4,364,465 OrdinaryShares, representing 2.97% of the issued share capital. Following Admission, FMS will have a residual interest in 31,499,725 OrdinaryShares, representing 21.47% of the issued share capital. Commenting on the Placing, Jim Murray-Smith, Chief Executive of Hardide Plc,said: "The proceeds from the Placing will enable the Company to strengthen thesenior management team, underpin and accelerate expansion in the US. Initialindications from the US oil, gas and pump markets continue to suggest extremelyhigh demand for Hardide's unique products. The opening of our new manufacturingfacility in Houston is still on schedule for October 2006. We have been particularly encouraged by the strong demand from both existing andnew institutional investors and look forward to sharing Hardide's future successwith them. The Board remains confident of meeting market expectations for thefull year." For further information: Hardide plc Jim Murray Smith, Chief Executive Tel: +44 (0) 1869 353 830 jmurray-smith@hardide.com www.hardide.com Daniel Stewart & Company plc Paul Shackleton, Corporate Finance Tel: +44 (0) 20 7776 6550 www.danielstewart.co.uk Media enquiries: Abchurch Chris Lane / Katherine Murphy Tel: +44 (0) 20 7398 7700 chris.lane@abchurch-group.com www.abchurch-group.com Notes to editors Hardide provides and applies tungsten carbide coatings to a wide range ofengineering components. The Company's patented technology is unique in that itcombines both abrasion and corrosion resistant properties in one coating. Whenapplied to components, the technology is proven to offer dramatic cost savingsthrough reduced downtime and extended component life. Customers include leadingcompanies operating in oil and gas exploration and production, valve and pumpsmanufacturing and general engineering. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 20215:37 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components
8th Jul 20197:00 amRNSContract Award
28th Jun 20197:00 amRNSExercise of Options and Director Shareholdings
11th Jun 20195:00 pmRNSHolding(s) in Company
14th May 20197:00 amRNSInterim Results
14th May 20197:00 amRNSHardide selected for Airbus A380 wing components
13th Mar 20197:00 amRNSHardide Coating Extends Life of Turbine Blades
7th Mar 201911:37 amRNSHolding(s) in Company
7th Mar 201911:36 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.